Teladoc Health to Announce First-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Needham & Company Starts Teladoc (TDOC) at Buy
April 15, 2021 5:38 AM EDTNeedham & Company analyst Ryan MacDonald initiates coverage on Teladoc (NYSE: TDOC) with a Buy rating and a price target of $235.00.
The analyst comments "While Teladoc's market-leading position placed the company in a prime position to benefit from the pandemic-driven surge in adoption of... More



